{"url_path":"/sec/rmtg/10-q/2026/item-1a","section_key":"item-1a","section_title":"Item 1A Risk Factors**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-06-09","source_url":"https://www.sec.gov/Archives/edgar/data/1760026/0001213900-26-066838-index.html","accession_number":"0001213900-26-066838","cik":"0001760026","ticker":"RMTG","issuer_name":"Regenerative Medical Technology Group Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1760026/0001213900-26-066838-index.html","primary_entity_key":"0001760026","primary_entity_name":"Regenerative Medical Technology Group Inc."},"word_count":158,"has_tables":true,"body_markdown":"**Item\n1A. Risk Factors**\n\n \n\nOur business faces many risks, a number of which\nare described in the section captioned “Risk Factors” in our Annual Report for the year ended December 31, 2025, filed with\nthe SEC on May 19, 2026. The risks described may not be the only risks we face. Other risks of which we are not yet aware, or that we\ncurrently believe are not material, may also materially and adversely impact our business operations or financial results. If any of the\nevents or circumstances described in the risk factors contained in our Annual Report occur, our business, financial condition or results\nof operations could be adversely impacted and the value of an investment in our securities could decline. Investors and prospective investors\nshould consider the risks described in our Annual Report, and the information contained in the section captioned “Forward-Looking\nStatements” and elsewhere in this Quarterly Report before deciding whether to invest in our securities."}